SCHEDULE: SeaStar Medical Holding Corp. Ownership Filing

Intracoastal Capital LLC, along with individuals Mitchell P. Kopin and Daniel B. Asher, reported beneficial ownership of 443,253 shares of SeaStar Medical Holding Corporation common stock, representing 9.99% of the outstanding shares as of March 31, 2026.

Summary

• This filing is a Schedule 13G, an amendment to a previous filing, reporting beneficial ownership of SeaStar Medical Holding Corporation common stock.
• The reporting persons are Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC.
• As of March 31, 2026, the reporting persons collectively beneficially owned 443,253 shares of common stock.
• This ownership represents approximately 9.99% of the class of securities.
• The reported shares are primarily issuable upon the exercise of various warrants held by Intracoastal Capital LLC.
• The filing notes that certain shares issuable under warrants are excluded due to 'blocker provisions' that limit beneficial ownership to 9.99% or 4.99% of the common stock.
• Without these blocker provisions, the reporting persons could potentially beneficially own 534,285 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is a routine disclosure of beneficial ownership and does not provide new operational or financial information about the company itself.

Positives

• The reporting persons hold a significant stake, just under the 10% threshold that typically triggers more stringent reporting requirements.
• The existence of warrants indicates potential future investment or commitment to the company's stock.

Negatives

• The 'blocker provisions' in the warrants suggest a deliberate strategy to avoid crossing ownership thresholds, potentially indicating a cautious approach or a need to manage regulatory implications.
• The filing does not provide details on the financial health or operational performance of SeaStar Medical Holding Corporation, focusing solely on ownership.

Risks

• The reliance on warrants for a significant portion of the reported ownership means the actual number of shares held can fluctuate based on warrant exercise and market conditions.
• The 'blocker provisions' could limit the reporting persons' ability to increase their stake beyond certain thresholds without triggering additional disclosure or regulatory scrutiny.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance. It solely focuses on current ownership details.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant shareholders to report their holdings. The use of blocker provisions is a strategic maneuver often employed to manage ownership percentages and comply with regulatory thresholds, particularly in companies with a substantial number of outstanding warrants.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding significant ownership stakes, which can influence market perception and trading activity.
• Management: The reporting persons' stake may indicate a level of confidence or interest in the company's strategy, potentially influencing management decisions.
• Creditors: No direct impact is indicated, as the filing focuses on equity ownership.

Next Steps

• The reporting persons will continue to monitor their beneficial ownership levels in SeaStar Medical Holding Corporation.
• Future warrant exercises or dispositions of shares will necessitate updated filings if ownership thresholds are crossed.

Key Dates

Keywords

SeaStar Medical Holding Corporation, Schedule 13G, Beneficial Ownership, Intracoastal Capital LLC, Mitchell P. Kopin, Daniel B. Asher, Warrants, Blocker Provisions, SEC Filing, Common Stock